wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q34650994-514246F9-624C-4DE7-9920-0D562A92D86C
Q34650994-514246F9-624C-4DE7-9920-0D562A92D86C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34650994-514246F9-624C-4DE7-9920-0D562A92D86C
EGFR Mutation Positive Stage IV Non-Small-Cell Lung Cancer: Treatment Beyond Progression
P2860
Q34650994-514246F9-624C-4DE7-9920-0D562A92D86C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34650994-514246F9-624C-4DE7-9920-0D562A92D86C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d0ac67026afed732beee80c21aa79c2b93b27809
P2860
A phase 2 trial of dacomitinib (PF-00299804), an oral, irreversible pan-HER (human epidermal growth factor receptor) inhibitor, in patients with advanced non-small cell lung cancer after failure of prior chemotherapy and erlotinib.